WO2012155226A8 - Processo para a produção de derivados de pyrostegia venusta, derivados de pyrostegia venusta, composições farmacêuticas e seus usos - Google Patents

Processo para a produção de derivados de pyrostegia venusta, derivados de pyrostegia venusta, composições farmacêuticas e seus usos Download PDF

Info

Publication number
WO2012155226A8
WO2012155226A8 PCT/BR2012/000136 BR2012000136W WO2012155226A8 WO 2012155226 A8 WO2012155226 A8 WO 2012155226A8 BR 2012000136 W BR2012000136 W BR 2012000136W WO 2012155226 A8 WO2012155226 A8 WO 2012155226A8
Authority
WO
WIPO (PCT)
Prior art keywords
derivatives
venusta
pyrostegia
pharmaceutical compositions
producing
Prior art date
Application number
PCT/BR2012/000136
Other languages
English (en)
French (fr)
Other versions
WO2012155226A1 (pt
Inventor
Jardel Massari
Ana Maria Soares PEREIRA
Sarazete Izidia Vaz PEREIRA
Camilla HERNANDES
Bianca Waleria Bertoni
Silvia Helena Taleb CONTINI
Original Assignee
Biotec-Bio Tecnologia Ltda
Associação De Ensino De Ribeirão Preto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotec-Bio Tecnologia Ltda, Associação De Ensino De Ribeirão Preto filed Critical Biotec-Bio Tecnologia Ltda
Priority to EP12785864.5A priority Critical patent/EP2742946A4/en
Priority to US14/117,625 priority patent/US20150126465A1/en
Publication of WO2012155226A1 publication Critical patent/WO2012155226A1/pt
Publication of WO2012155226A8 publication Critical patent/WO2012155226A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Abstract

A presente invenção trata de processo para a produção de compostos derivados da planta Pyrostegia venusta (P. venusta), composições farmacêuticas compreendendo os mesmos e seus usos medicamentosos, notadamente como antimicrobiano.
PCT/BR2012/000136 2011-05-13 2012-05-14 Processo para a produção de derivados de pyrostegia venusta, derivados de pyrostegia venusta, composições farmacêuticas e seus usos WO2012155226A1 (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP12785864.5A EP2742946A4 (en) 2011-05-13 2012-05-14 PROCESS FOR THE PRODUCTION OF PYROSTEGIA VENUSTA DERIVATIVES, PYROSTEGIA VENUSTA DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
US14/117,625 US20150126465A1 (en) 2011-05-13 2012-05-14 Process for producing derivatives of pyrostegia venusta, derivatives of pyrostegia venusta, pharmaceutical compositions and its uses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI1102578-6A BRPI1102578B1 (pt) 2011-05-13 2011-05-13 Processo para a produção de derivados de pyrostegia venusta, composições farmacêuticas e uso de derivado de pyrostegia venusta
BRPI1102578-6 2011-05-13

Publications (2)

Publication Number Publication Date
WO2012155226A1 WO2012155226A1 (pt) 2012-11-22
WO2012155226A8 true WO2012155226A8 (pt) 2013-01-03

Family

ID=47176066

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2012/000136 WO2012155226A1 (pt) 2011-05-13 2012-05-14 Processo para a produção de derivados de pyrostegia venusta, derivados de pyrostegia venusta, composições farmacêuticas e seus usos

Country Status (4)

Country Link
US (1) US20150126465A1 (pt)
EP (1) EP2742946A4 (pt)
BR (1) BRPI1102578B1 (pt)
WO (1) WO2012155226A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104569256B (zh) * 2014-12-22 2016-01-27 浙江中烟工业有限责任公司 一种采用液相色谱-串联质谱测定水基胶中3种异噻唑啉酮防腐剂的方法
US9937118B2 (en) * 2016-06-21 2018-04-10 Johnson & Johnson Consumer Inc. Clear suspending personal care cleansing compositions
CN104991003B (zh) * 2015-07-06 2017-06-16 深圳出入境检验检疫局工业品检测技术中心 一种纺织品中异噻唑啉酮类抗菌整理剂的测定方法
CN109043059A (zh) * 2018-10-23 2018-12-21 广州城市职业学院 炮仗花茶的制作方法
CN109221542A (zh) * 2018-10-24 2019-01-18 广州城市职业学院 一种炮仗花植物饮料及其生产方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012048119A2 (en) * 2010-10-06 2012-04-12 The Board Of Trustees Of The University Of Arkansas Anti-biofilm compositions and methods for using

Also Published As

Publication number Publication date
EP2742946A1 (en) 2014-06-18
BRPI1102578A2 (pt) 2016-10-11
EP2742946A4 (en) 2015-05-06
US20150126465A1 (en) 2015-05-07
WO2012155226A1 (pt) 2012-11-22
BRPI1102578B1 (pt) 2021-09-28

Similar Documents

Publication Publication Date Title
WO2013091775A3 (de) Verwendung von cyclohexanolderivaten als antimikrobielle wirkstoffe
ZA201405101B (en) "new indolizine compounds, a process for their preparation and pharmaceutical compositions containing them."
EP2522653A4 (en) BIGUANIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE BIGUANIDE DERIVATIVE AS AN ACTIVE SUBSTANCE
WO2014097151A3 (en) Autotaxin inhibitors
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
CA2830549C (en) Methods and compositions for preparing noribogaine from voacangine
WO2011130615A3 (en) Preparation of lacosamide
WO2010092090A3 (en) Novel salts of sitagliptin
WO2010049454A3 (en) Antimicrobial composition from copepods
ZA201301463B (en) Pharmaceutical compositions for calonolides,their derivatives and analogues,and process for producing the same
WO2013080217A3 (en) Crystalline forms of carbazitaxel and process for preparation thereof
WO2011157722A3 (en) Solid ivabradine-containing composition
WO2012037562A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
IN2012DN02793A (pt)
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
WO2014076263A3 (fr) Composition pour pralinage de racines de plantes
WO2011122872A3 (ko) 쿠메스트롤 또는 쿠메스트롤을 포함하는 콩 추출물 포함 조성물
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
WO2014179567A3 (en) Methods and compositions for treating beta-thalassemia and sickle cell disease
WO2012137227A3 (en) Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof
WO2012155226A8 (pt) Processo para a produção de derivados de pyrostegia venusta, derivados de pyrostegia venusta, composições farmacêuticas e seus usos
WO2013100718A3 (ko) 라저스트로에미아 오바리폴리아 추출물 또는 이의 분획물을 유효성분으로 포함하는 염증성 질환 또는 천식의 예방 또는 치료용 약학적 조성물
MX2013004878A (es) N-hetarilmetil pirazolilcarboxamidas.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12785864

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2012785864

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012785864

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 14117625

Country of ref document: US